Zhitong Finance App News, Bide Pharmaceutical (688073.SH) issued an announcement. The restricted shares currently listed and circulated are part of the company's initial public offering of restricted shares. The sales restriction period is 36 months from the date the registration of the commercial change to acquire the company's shares is completed. The number of restricted shares listed and in circulation is 5.162,200 shares, accounting for 5.68% of the company's total share capital, and the number of shareholders corresponding to restricted shares is 7. The current sales restriction period for this part of the restricted shares is about to expire, and they will be listed and circulated on March 25, 2024.